Torray Investment Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.6M Buy
95,042
+69,195
+268% +$12.8M 2.56% 13
2025
Q1
$5.42M Sell
25,847
-4,824
-16% -$1.01M 0.81% 45
2024
Q4
$5.45M Buy
30,671
+9,107
+42% +$1.62M 0.78% 46
2024
Q3
$4.26M Buy
21,564
+20
+0.1% +$3.95K 0.6% 52
2024
Q2
$3.7M Buy
21,544
+293
+1% +$50.3K 0.55% 56
2024
Q1
$3.87M Buy
21,251
+650
+3% +$118K 0.58% 52
2023
Q4
$3.19M Sell
20,601
-589
-3% -$91.3K 0.52% 54
2023
Q3
$3.16M Buy
21,190
+2,446
+13% +$365K 0.56% 54
2023
Q2
$2.53M Buy
18,744
+27
+0.1% +$3.64K 0.44% 59
2023
Q1
$2.98M Buy
18,717
+229
+1% +$36.5K 0.54% 55
2022
Q4
$2.99M Buy
18,488
+239
+1% +$38.6K 0.54% 55
2022
Q3
$2.45M Buy
18,249
+1,217
+7% +$163K 0.49% 54
2022
Q2
$2.61M Buy
17,032
+206
+1% +$31.6K 0.5% 59
2022
Q1
$2.73M Sell
16,826
-3,703
-18% -$600K 0.44% 61
2021
Q4
$2.78M Buy
20,529
+776
+4% +$105K 0.41% 59
2021
Q3
$2.13M Buy
19,753
+228
+1% +$24.6K 0.33% 61
2021
Q2
$2.2M Sell
19,525
-65
-0.3% -$7.32K 0.32% 62
2021
Q1
$2.12M Sell
19,590
-21
-0.1% -$2.27K 0.33% 58
2020
Q4
$2.1M Sell
19,611
-986
-5% -$106K 0.35% 55
2020
Q3
$1.8M Buy
20,597
+108
+0.5% +$9.46K 0.33% 59
2020
Q2
$2.01M Sell
20,489
-2,765
-12% -$272K 0.38% 53
2020
Q1
$1.77M Sell
23,254
-6,095
-21% -$464K 0.39% 53
2019
Q4
$2.6M Sell
29,349
-463
-2% -$41K 0.45% 54
2019
Q3
$2.26M Buy
29,812
+276
+0.9% +$20.9K 0.25% 59
2019
Q2
$2.15M Buy
29,536
+2,583
+10% +$188K 0.22% 62
2019
Q1
$2.17M Buy
26,953
+2,707
+11% +$218K 0.23% 57
2018
Q4
$2.24M Buy
24,246
+3,787
+19% +$349K 0.27% 57
2018
Q3
$1.94M Buy
20,459
+2,645
+15% +$250K 0.19% 64
2018
Q2
$1.65M Buy
17,814
+2,584
+17% +$239K 0.17% 66
2018
Q1
$1.44M Sell
15,230
-869
-5% -$82.3K 0.15% 69
2017
Q4
$1.56M Buy
16,099
+1,714
+12% +$166K 0.15% 67
2017
Q3
$1.28M Buy
14,385
+740
+5% +$65.7K 0.13% 66
2017
Q2
$989K Buy
13,645
+2,220
+19% +$161K 0.1% 67
2017
Q1
$744K Buy
11,425
+1,635
+17% +$106K 0.08% 69
2016
Q4
$613K Buy
9,790
+740
+8% +$46.3K 0.07% 96
2016
Q3
$571K Hold
9,050
0.06% 69
2016
Q2
$560K Buy
+9,050
New +$560K 0.04% 69